InvestorsHub Logo
Followers 0
Posts 183
Boards Moderated 0
Alias Born 09/10/2016

Re: None

Sunday, 12/16/2018 7:01:10 AM

Sunday, December 16, 2018 7:01:10 AM

Post# of 58837
Manufacturers see adding dna tracing as complicated,
unwieldy, and evermore, as redundant to other tracking tech.

With blockchain, even in barcode ink, it is being obsoleted.

Linearx is a cry for help. Yet it is their only hope.

No credible pharma company shows interest, yet at Investor day
the only analyst (Maxim) wanted to know where they would
locate their “off the shelf” cancer cure dispensers.

It is a long and complex path to FDA approval, requiring many
millions of dollars, and years of research, usually associated
with companies that have the resources to fund and coordinate
the efforts.

I think that if their medical dna was as revolutionary as claimed,
they would have successfully shopped it by now.

Instead, they are reduced to employee funding, and last gasping
about their final rainbow.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News